More importantly, GHSR signaling is also an attractive target for the therapy of obesity-related metabolic disease; however a study showed that its ligand, ghrelin, was lower in obese subjects than in a normal group (53). The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.